Income statement (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | 2 353.89 | 4 467.90 | 4 321.55 |
| Employee benefit expenses | - 482.27 | -2 466.53 | -1 522.27 |
| EBIT | 1 871.62 | 2 001.36 | 2 799.28 |
| Other financial income | 0.36 | 40.86 | 31.49 |
| Other financial expenses | -5.15 | -6.83 | -4.06 |
| Pre-tax profit | 1 866.83 | 2 035.39 | 2 826.71 |
| Income taxes | - 415.35 | - 450.19 | - 623.92 |
| Net earnings | 1 451.48 | 1 585.21 | 2 202.79 |
Assets (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Investments total | |||
| Long term receivables total | |||
| Inventories total | |||
| Current amounts owed by group member comp. | 1 805.00 | 1 422.23 | 971.53 |
| Prepayments and accrued income | 72.03 | ||
| Current other receivables | 4.09 | 0.60 | |
| Short term receivables total | 1 805.00 | 1 498.35 | 972.13 |
| Cash and bank deposits | 566.24 | 1 053.74 | 2 607.22 |
| Cash and cash equivalents | 566.24 | 1 053.74 | 2 607.22 |
| Balance sheet total (assets) | 2 371.24 | 2 552.09 | 3 579.35 |
Equity and liabilities (kDKK)
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 1 450.00 | 1 580.00 | 2 200.00 |
| Retained earnings | -1 450.00 | -1 578.52 | -2 193.31 |
| Profit of the financial year | 1 451.48 | 1 585.21 | 2 202.79 |
| Shareholders equity total | 1 491.48 | 1 626.69 | 2 249.47 |
| Non-current liabilities total | |||
| Current loans from credit institutions | 67.44 | 61.94 | |
| Current trade creditors | 247.33 | 138.10 | 16.06 |
| Short-term deferred tax liabilities | 415.35 | 450.19 | 623.92 |
| Other non-interest bearing current liabilities | 217.08 | 269.67 | 627.96 |
| Current liabilities total | 879.76 | 925.40 | 1 329.88 |
| Balance sheet total (liabilities) | 2 371.24 | 2 552.09 | 3 579.35 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.